Drug Profile
Diclofenac injection - Hospira
Alternative Names: DylojectLatest Information Update: 17 Dec 2021
Price :
$50
*
At a glance
- Originator Javelin Pharmaceuticals
- Developer Hospira; Javelin Pharmaceuticals
- Class Antipyretics; Antirheumatics; Non-opioid analgesics; Nonsteroidal anti-inflammatories; Phenylacetates; Small molecules
- Mechanism of Action Cyclooxygenase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Postoperative pain
Most Recent Events
- 18 Jun 2015 Launched for Postoperative pain in USA (IV) before June 2015
- 30 Dec 2014 Registered for Postoperative pain in USA (IV)
- 31 Dec 2013 Hospira receives a second complete response letter from the US FDA for injectable diclofenac in Postoperative pain